Trends in the Utilization and Impact of Radiofrequency Ablation for Hepatocellular Carcinoma

Journal of the American College of Surgeons

Volumn 210, Issue 4, 2010, Pages 441-448

  Massarweh, Nader N ^a,b   Park, James O ^a   Farjah, Farhood ^a,b   Yeung, Raymond S W ^a   Symons, Rebecca Gaston ^b   Vaughan, Thomas L ^b   Baldwin, Laura Mae ^a,b   Flum, David R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HEPATITIS C; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES;

EID: 77949889477     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.12.026     Document Type: Article

References (37)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2 (2001) 533-543
2. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
3. Altekruse S.F., McGlynn K.A., and Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27 (2009) 1485-1491
4. Donckier V., Van Laethem J.L., Van Gansbeke D., et al. New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. J Surg Oncol 84 (2003) 36-44 discussion 44
5. Davis G.L., Albright J.E., Cook S.F., and Rosenberg D.M. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 9 (2003) 331-338
6. Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (2005) 225-235
7. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
8. Marchesini G., Brizi M., Morselli-Labate A.M., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107 (1999) 450-455
9. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
10. Harrison S.A., Torgerson S., and Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98 (2003) 2042-2047
11. McCullough A.J. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8 (2004) 521-533 viii
12. Chen M.S., Li J.Q., Zheng Y., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243 (2006) 321-328
13. Livraghi T., Meloni F., Di Stasi M., et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?. Hepatology 47 (2008) 82-89
14. Takahashi S., Kudo M., Chung H., et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72 (2007) 98-103
15. Takahashi S., Kudo M., Chung H., et al. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis 25 (2007) 303-309
16. Sonnenday C.J., Dimick J.B., Schulick R.D., and Choti M.A. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma. J Gastrointest Surg 11 (2007) 1636-1646 discussion 1646
17. Schwarz R.E., and Smith D.D. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 195 (2008) 829-836
18. Surveillance, Epidemilogy, and End Results. www.seer.cancer.gov Accessed January 7, 2010
19. Bach P.B., Guadagnoli E., Schrag D., et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40 (2002) IV-19-25
20. Nathan H., Schulick R.D., Choti M.A., and Pawlik T.M. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249 (2009) 799-805
21. Farinati F., Sergio A., Baldan A., et al. Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter?. A multi-center study. BMC Cancer 9 (2009) 33
22. Breslow N.E., and Day N.E. Statistical methods in cancer research. Volume I - The analysis of case-control studies. Lyon, France: IARC Sci Publ (1980) 5-338
23. Curley S.A. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol 15 (2008) 11-13
24. Strasberg S.M., and Ludbrook P.A. Who oversees innovative practice?. Is there a structure that meets the monitoring needs of new techniques?. J Am Coll Surg 196 (2003) 938-948
25. Lam C.M., Ng K.K., Poon R.T., et al. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg 91 (2004) 334-338
26. Johnson E.W., Holck P.S., Levy A.E., et al. The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 139 (2004) 825-829 discussion 829-830
27. Rodriguez-Sanjuan J.C., Gonzalez F., Juanco C., et al. Radiological and pathological assessment of hepatocellular carcinoma response to radiofrequency. A study on removed liver after transplantation. World J Surg 32 (2008) 1489-1494
28. Lu D.S., Yu N.C., Raman S.S., et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234 (2005) 954-960
29. Yamanaka N., Tanaka T., Tanaka W., et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 79 (1997) 1509-1515
30. Huang Y.H., Wu J.C., Chen C.H., et al. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 25 (2005) 236-241
31. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
32. Ahmad A., Chen S.L., Kavanagh M.A., et al. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?. Am Surg 72 (2006) 875-879
33. Hogan C., Lunney J., Gabel J., and Lynn J. Medicare beneficiaries' costs of care in the last year of life. Health Aff (Millwood) 20 (2001) 188-195
34. Farjah F., Flum D.R., Varghese Jr. T.K., et al. Surgeon specialty and long-term survival after pulmonary resection for lung cancer. Ann Thorac Surg 87 (2009) 995-1004 discussion 1005-1006
35. Abu-Hilal M., Primrose J.N., Casaril A., et al. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12 (2008) 1521-1526
36. Mulier S., Ni Y., Jamart J., et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242 (2005) 158-171
37. Molinari M., and Helton S. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg 198 (2009) 396-406